Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 1204-1211 |
Journal | Haematologica |
Volume | 99 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2014 |
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
T.P. Hughes, A Hochhaus, H.M. Kantarjian, F. Cervantes, F. Guilhot, D. Niederwieser, P.D. le Coutre, G. Rosti, G.J. Ossenkoppele, C. Lobo, H. Shibayama, X.L. Fan, H.D. Menssen, C. Kemp, R.A. Larson, G. Saglio
Research output: Contribution to journal › Article › Academic › peer-review